Clinical Trials Directory

Trials / Conditions / Stage IIB Non-Small Cell Lung Carcinoma

Stage IIB Non-Small Cell Lung Carcinoma

9 registered clinical trials studyying Stage IIB Non-Small Cell Lung Carcinoma.

StatusTrialSponsorPhase
TerminatedNivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Ca
NCT03366766
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityPhase 2
CompletedDynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer
NCT03091816
University of Southern California—
CompletedS1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
NCT02728596
SWOG Cancer Research NetworkN/A
CompletedPhotodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed b
NCT01854684
Roswell Park Cancer InstitutePhase 1
CompletedPET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stag
NCT02073968
Albert Einstein College of MedicinePhase 2
TerminatedAzacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Under
NCT01886573
National Cancer Institute (NCI)Phase 1
TerminatedPioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer
NCT01342770
National Cancer Institute (NCI)Phase 2
CompletedA Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable
NCT00963807
National Cancer Institute (NCI)Phase 2
CompletedEF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung Cancer
NCT02154399
National Cancer Institute (NCI)Phase 2